[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559054":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":41,"responsibleParty":72,"collaborators":18,"id":74,"slug":75,"hasResults":76,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":18,"eligibilityCriteria":80,"healthyVolunteers":76,"sex":81,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":18,"studyType":87,"phases":88,"briefSummary":90,"conditions":91,"keywords":96,"overallStatus":102,"whyStopped":18,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Texas Scottish Rite Hospital for Children","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Peripheral Nerve Block (PNB) group","ACTIVE_COMPARATOR","* A 20 mL Adductor PNB will be injected where determined as best place by anesthesiologist\n* Patient will receive 0.2% plain Ropivacaine (perineural injection) regardless of weight\n* Patient will be given a purple surgical marker dot at\u002Fnear the site of injection by the anesthesiologist",[13],"Drug: Ropivacaine 0.2% Injectable Solution",{"label":15,"type":16,"description":17,"interventionNames":18},"No Peripheral Nerve Block (PNB) group","NO_INTERVENTION","\\- Patients will be given a purple surgical marker dot at\u002Fnear the site where a PNB would be administered by the anesthesiologist, if they were randomized to the placebo group",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Ropivacaine 0.2% Injectable Solution","Patients who are randomized to the peripheral nerve block group will receive a pre-operative perineural injection of 0.2% plain Ropivacaine regardless of weight.",[9],[26],"Naropin",[28],{"name":29,"affiliation":5,"role":30},"Philip Wilson, MD","PRINCIPAL_INVESTIGATOR",[32,37],{"name":33,"role":34,"phone":35,"phoneExt":18,"email":36},"Robert Van Pelt, MPH","CONTACT","2145597456","bobby.vanpelt@tsrh.org",{"name":38,"role":34,"phone":39,"phoneExt":18,"email":40},"Anna Wilhelmy, MS","469-857-2109","anna.wilhelmy@tsrh.org",[42],{"facility":5,"status":18,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Frisco","Texas","75034","United States","US",{"type":49,"coordinates":50},"Point",[51,52],-96.82361,33.15067,{"lat":52,"lon":51},[55,57,58,59,62,64,66,68,70],{"name":33,"role":34,"phone":56,"phoneExt":18,"email":36},"214-559-7456",{"name":38,"role":34,"phone":39,"phoneExt":18,"email":40},{"name":29,"role":30,"phone":18,"phoneExt":18,"email":18},{"name":60,"role":61,"phone":18,"phoneExt":18,"email":18},"Henry Ellis, MD","SUB_INVESTIGATOR",{"name":63,"role":61,"phone":18,"phoneExt":18,"email":18},"John Arvesen, MD",{"name":65,"role":61,"phone":18,"phoneExt":18,"email":18},"Cody Todesco, PA",{"name":67,"role":61,"phone":18,"phoneExt":18,"email":18},"Benjamin Johnson, PA",{"name":69,"role":61,"phone":18,"phoneExt":18,"email":18},"Charles Wyatt, CPNP",{"name":71,"role":61,"phone":18,"phoneExt":18,"email":18},"Stephanie Stutz, MS",{"type":73,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100559054","phase-2-evaluation-of-pain-management-after-surgery-when-using-nerve-blocks-in-the-pediatric-population-100559054",false,"NCT06559137","Evaluation of Pain Management After Surgery When Using Nerve Blocks in the Pediatric Population","Prospective Evaluation of Post-operative Pain Management Using Peripheral Nerve Blocks in the Pediatric Population","Inclusion Criteria:\n\n* Must be aged 13+ years at time of surgery\n* Must present with injury requiring an ACLR procedure with a Bone Patellar Tendon Bone or Quadriceps graft\n* Ability to provide assent, legally appointed representative available to provide informed consent\n\nExclusion Criteria:\n\n* Patient \\\u003C13 years old\n* Requires fracture repair or another non-standardized surgery\n* Any ACLR that requires the use of a graft type other than Bone Patellar Tendon Bone or Quadriceps tendon\n* Any lower extremity procedure that is not primarily an ACLR\n* Patient pregnancy\n* Inability to provide assent or legally appointed representative to provide informed consent\n* Prior history of hypersensitivity to Ropivacaine or any local anesthesia\n* BMI ≥ 40","ALL","13 Years","21 Years",{"count":85,"type":86},160,"ESTIMATED","INTERVENTIONAL",[89],"PHASE2","The goal of this randomized clinical trial is to determine if single-shot ropivacaine peripheral nerve blocks (PNB - perineural injections) for anterior cruciate ligament (ACL) reconstruction procedures in pediatric orthopaedic sports medicine patients provides significant pain relief and decreased narcotic use. The main questions it aims to answer are:\n\n* Does ropivacaine significantly reduce Visual Analog Scale (VAS) pain scores and pain levels up to one week postoperatively?\n* Does ropivacaine significantly decrease narcotic use (number of pills taken) up to one week postoperatively?\n\nResearchers will compare the pain outcomes and narcotic use of participants who receive a single-shot ropivacaine peripheral nerve block to those of participants who do not receive a single-shot ropivacaine peripheral nerve block for their ACL reconstruction surgery. The goal is to understand if there is a significant difference in participant pain outcomes and narcotic use outside the first 24 hours postoperatively.\n\nParticipants will:\n\n* receive either a single-shot ropivacaine peripheral nerve block intraoperatively or no peripheral nerve block during their ACL Quadriceps tendon graft or bone patellar tendon bone graft reconstruction surgery.\n* receive and complete questionnaires at postoperative days 1, 4, and 7 regarding their pain scores, levels, and outcomes, effective pain treatments, overall pain interference, narcotic use (number of pills taken), and overall pain treatment satisfaction\n* receive and complete secondary outcome measures of functional and psychological outcomes regarding their ACL reconstruction surgery at postoperative day 1",[92,93,94,95],"Anterior Cruciate Ligament (ACL) Tear","Sports Injuries in Children","Analgesia","Pain, Postoperative",[97,98,99,100,101],"Narcotic use","Postoperative pain management","ACL reconstruction","Visual Analog Scale (VAS) pain scores","Multimodal pain management protocol","NOT_YET_RECRUITING","2025-09-09",{"date":105,"type":106},"2025-09-16","ACTUAL",{"date":108,"type":86},"2025-09",{"date":110,"type":86},"2028-09",{"name":5,"class":6},1]